GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Global Corp (ASX:AVR) » Definitions » Price-to-Owner-Earnings

Anteris Technologies Global (ASX:AVR) Price-to-Owner-Earnings : (As of May. 22, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Global Price-to-Owner-Earnings?

As of today (2025-05-22), Anteris Technologies Global's share price is A$5.86. Anteris Technologies Global does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Anteris Technologies Global's Price-to-Owner-Earnings or its related term are showing as below:


ASX:AVR's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.71
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-22), Anteris Technologies Global's share price is A$5.86. Anteris Technologies Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-5.81. Therefore, Anteris Technologies Global's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-22), Anteris Technologies Global's share price is A$5.86. Anteris Technologies Global's EPS without NRI for the trailing twelve months (TTM) ended in was A$-5.81. Therefore, Anteris Technologies Global's PE Ratio without NRI for today is At Loss.


Anteris Technologies Global Price-to-Owner-Earnings Historical Data

The historical data trend for Anteris Technologies Global's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Global Price-to-Owner-Earnings Chart

Anteris Technologies Global Annual Data
Trend Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Anteris Technologies Global Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Anteris Technologies Global's Price-to-Owner-Earnings

For the Medical Devices subindustry, Anteris Technologies Global's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Price-to-Owner-Earnings falls into.


;
;

Anteris Technologies Global Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Anteris Technologies Global's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=5.86/-5.95
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies Global  (ASX:AVR) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Anteris Technologies Global Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Anteris Technologies Global's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies Global Business Description

Traded in Other Exchanges
N/A
Address
9 Sherwood Road, Level 3, Suite 302, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.